Otto H. Postma
Private Equity Investor at MedSciences Capital Management BV
Profile
Otto H.
Postma co-founded (the predecessor of) Pharming Group N.V., founded and managed Pharming Healthcare, Inc., and was instrumental in the establishment or early development of several Dutch life sciences start-ups.
He is experienced in commercial development, corporate strategy, licensing, and IP management.
Otto Postma received an MS degree in chemistry cum laude from Utrecht University.
Otto H. Postma active positions
Companies | Position | Start |
---|---|---|
MedSciences Capital Management BV
MedSciences Capital Management BV Investment ManagersFinance MedSciences Capital Management BV (MSCM) is a venture capital investment firm located in Amsterdam. MSCM is part of Kempen & Co. N.V., a Dutch merchant bank offering asset management, corporate finance, and security trading services. In turn, Kempen & Co. is part of F. van Lanschot Bankiers NV group (XA: LANS). MSCM manages three closed-end funds: MedSciences Capital BV, MedSciences Capital II BV and MedSciences Seed Fund BV. | Private Equity Investor | 2005-12-31 |
Former positions of Otto H. Postma
Companies | Position | End |
---|---|---|
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Director/Board Member | - |
Training of Otto H. Postma
University of Utrecht | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
MedSciences Capital Management BV
MedSciences Capital Management BV Investment ManagersFinance MedSciences Capital Management BV (MSCM) is a venture capital investment firm located in Amsterdam. MSCM is part of Kempen & Co. N.V., a Dutch merchant bank offering asset management, corporate finance, and security trading services. In turn, Kempen & Co. is part of F. van Lanschot Bankiers NV group (XA: LANS). MSCM manages three closed-end funds: MedSciences Capital BV, MedSciences Capital II BV and MedSciences Seed Fund BV. | Finance |
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
- Stock Market
- Insiders
- Otto H. Postma